Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas

Henk M W Verheul, Klaas Hoekman, Florea Lupu, Henk J. Broxterman, Paul Van Der Valk, Ajay K. Kakkar, Herbert M. Pinedo

Research output: Contribution to journalArticle

Abstract

Angiogenesis and activated blood coagulation are involved in tumor growth and metastasis. Although some have suggested that activation of coagulation in tumors is not linked to activation of platelets, no data exist to either support or refute this concept. However, platelet turnover in cancer patients is often increased, and platelets are carriers of angiogenic growth factors. We hypothesized that platelets are involved in tumor- associated angiogenesis. To obtain evidence supporting this hypothesis, we have studied whether the angiogenic and coagulation pathways and platelets are concomitantly activated in cancer patients with soft tissue sarcomas (STSs) using a novel method to detect activated platelets in tumor specimens. Twelve patients with STS were selected on the basis of having intratumoral accumulation of fluid, which was aspirated. These accumulations demonstrated very high concentrations of vascular endothelial growth factor and coagulation factors (including thrombin-antithrombin-complex). Tumor specimens showed dense vascularization with intense vascular endothelial growth factor expression and the presence of activated platelets. Taken together, these results support the concept that angiogenesis, blood coagulation, and platelets are concomitantly activated in STS and support the hypothesis that platelets contribute to tumor-induced angiogenesis.

Original languageEnglish (US)
Pages (from-to)166-171
Number of pages6
JournalClinical Cancer Research
Volume6
Issue number1
StatePublished - Jan 2000
Externally publishedYes

Fingerprint

Platelet Activation
Sarcoma
Vascular Endothelial Growth Factor A
Blood Platelets
Neoplasms
Blood Coagulation
Blood Coagulation Factors
Angiogenesis Inducing Agents
Intercellular Signaling Peptides and Proteins
Neoplasm Metastasis
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Verheul, H. M. W., Hoekman, K., Lupu, F., Broxterman, H. J., Van Der Valk, P., Kakkar, A. K., & Pinedo, H. M. (2000). Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clinical Cancer Research, 6(1), 166-171.

Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. / Verheul, Henk M W; Hoekman, Klaas; Lupu, Florea; Broxterman, Henk J.; Van Der Valk, Paul; Kakkar, Ajay K.; Pinedo, Herbert M.

In: Clinical Cancer Research, Vol. 6, No. 1, 01.2000, p. 166-171.

Research output: Contribution to journalArticle

Verheul, HMW, Hoekman, K, Lupu, F, Broxterman, HJ, Van Der Valk, P, Kakkar, AK & Pinedo, HM 2000, 'Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas', Clinical Cancer Research, vol. 6, no. 1, pp. 166-171.
Verheul HMW, Hoekman K, Lupu F, Broxterman HJ, Van Der Valk P, Kakkar AK et al. Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clinical Cancer Research. 2000 Jan;6(1):166-171.
Verheul, Henk M W ; Hoekman, Klaas ; Lupu, Florea ; Broxterman, Henk J. ; Van Der Valk, Paul ; Kakkar, Ajay K. ; Pinedo, Herbert M. / Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. In: Clinical Cancer Research. 2000 ; Vol. 6, No. 1. pp. 166-171.
@article{d2e4dd3c4add4e5ba6dcaaa772b43670,
title = "Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas",
abstract = "Angiogenesis and activated blood coagulation are involved in tumor growth and metastasis. Although some have suggested that activation of coagulation in tumors is not linked to activation of platelets, no data exist to either support or refute this concept. However, platelet turnover in cancer patients is often increased, and platelets are carriers of angiogenic growth factors. We hypothesized that platelets are involved in tumor- associated angiogenesis. To obtain evidence supporting this hypothesis, we have studied whether the angiogenic and coagulation pathways and platelets are concomitantly activated in cancer patients with soft tissue sarcomas (STSs) using a novel method to detect activated platelets in tumor specimens. Twelve patients with STS were selected on the basis of having intratumoral accumulation of fluid, which was aspirated. These accumulations demonstrated very high concentrations of vascular endothelial growth factor and coagulation factors (including thrombin-antithrombin-complex). Tumor specimens showed dense vascularization with intense vascular endothelial growth factor expression and the presence of activated platelets. Taken together, these results support the concept that angiogenesis, blood coagulation, and platelets are concomitantly activated in STS and support the hypothesis that platelets contribute to tumor-induced angiogenesis.",
author = "Verheul, {Henk M W} and Klaas Hoekman and Florea Lupu and Broxterman, {Henk J.} and {Van Der Valk}, Paul and Kakkar, {Ajay K.} and Pinedo, {Herbert M.}",
year = "2000",
month = "1",
language = "English (US)",
volume = "6",
pages = "166--171",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas

AU - Verheul, Henk M W

AU - Hoekman, Klaas

AU - Lupu, Florea

AU - Broxterman, Henk J.

AU - Van Der Valk, Paul

AU - Kakkar, Ajay K.

AU - Pinedo, Herbert M.

PY - 2000/1

Y1 - 2000/1

N2 - Angiogenesis and activated blood coagulation are involved in tumor growth and metastasis. Although some have suggested that activation of coagulation in tumors is not linked to activation of platelets, no data exist to either support or refute this concept. However, platelet turnover in cancer patients is often increased, and platelets are carriers of angiogenic growth factors. We hypothesized that platelets are involved in tumor- associated angiogenesis. To obtain evidence supporting this hypothesis, we have studied whether the angiogenic and coagulation pathways and platelets are concomitantly activated in cancer patients with soft tissue sarcomas (STSs) using a novel method to detect activated platelets in tumor specimens. Twelve patients with STS were selected on the basis of having intratumoral accumulation of fluid, which was aspirated. These accumulations demonstrated very high concentrations of vascular endothelial growth factor and coagulation factors (including thrombin-antithrombin-complex). Tumor specimens showed dense vascularization with intense vascular endothelial growth factor expression and the presence of activated platelets. Taken together, these results support the concept that angiogenesis, blood coagulation, and platelets are concomitantly activated in STS and support the hypothesis that platelets contribute to tumor-induced angiogenesis.

AB - Angiogenesis and activated blood coagulation are involved in tumor growth and metastasis. Although some have suggested that activation of coagulation in tumors is not linked to activation of platelets, no data exist to either support or refute this concept. However, platelet turnover in cancer patients is often increased, and platelets are carriers of angiogenic growth factors. We hypothesized that platelets are involved in tumor- associated angiogenesis. To obtain evidence supporting this hypothesis, we have studied whether the angiogenic and coagulation pathways and platelets are concomitantly activated in cancer patients with soft tissue sarcomas (STSs) using a novel method to detect activated platelets in tumor specimens. Twelve patients with STS were selected on the basis of having intratumoral accumulation of fluid, which was aspirated. These accumulations demonstrated very high concentrations of vascular endothelial growth factor and coagulation factors (including thrombin-antithrombin-complex). Tumor specimens showed dense vascularization with intense vascular endothelial growth factor expression and the presence of activated platelets. Taken together, these results support the concept that angiogenesis, blood coagulation, and platelets are concomitantly activated in STS and support the hypothesis that platelets contribute to tumor-induced angiogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0033968571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033968571&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 166

EP - 171

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 1

ER -